In a study with glioblastoma patients, cytotoxic T lymphocytes (CTLs) were engineered to express the herpes simplex virus type 1 thymidine kinase (HSV1-tk) alongside a glioblastoma-targeting interleukin-13 zetakine (353, 354). The gene discussed is IL13; the disease is glioblastoma.